392 related articles for article (PubMed ID: 12767751)
1. 25 years of the WHO essential medicines lists: progress and challenges.
Laing R; Waning B; Gray A; Ford N; 't Hoen E
Lancet; 2003 May; 361(9370):1723-9. PubMed ID: 12767751
[TBL] [Abstract][Full Text] [Related]
2. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
Baxi SM; Beall R; Yang J; Mackey TK
Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
[TBL] [Abstract][Full Text] [Related]
3. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
[TBL] [Abstract][Full Text] [Related]
4. [The essentiality and rationality of the Brazilian national listing of essential medicines].
Yamauti SM; Bonfim JR; Barberato-Filho S; Lopes LC
Cien Saude Colet; 2017 Mar; 22(3):975-986. PubMed ID: 28301004
[TBL] [Abstract][Full Text] [Related]
5. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
[TBL] [Abstract][Full Text] [Related]
6. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
[TBL] [Abstract][Full Text] [Related]
7. Essential medicines for children in Armenia.
Kazaryan I; Vardanyan L
Int J Risk Saf Med; 2015; 27 Suppl 1():S43-4. PubMed ID: 26639704
[TBL] [Abstract][Full Text] [Related]
8. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of essential medicines lists: the South African case study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
[TBL] [Abstract][Full Text] [Related]
10. Ensuring palliative medicine availability: the development of the IAHPC list of essential medicines for palliative care.
De Lima L; Krakauer EL; Lorenz K; Praill D; Macdonald N; Doyle D
J Pain Symptom Manage; 2007 May; 33(5):521-6. PubMed ID: 17482041
[TBL] [Abstract][Full Text] [Related]
11. GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.
Piggott T; Moja L; Jenei K; Kredo T; Skoetz N; Banzi R; Trapani D; Leong T; McCaul M; Lavis JN; Akl EA; Nonino F; Iorio A; Laurson-Doube J; Huttner BD; Schünemann HJ
J Clin Epidemiol; 2024 Feb; 166():111241. PubMed ID: 38123105
[TBL] [Abstract][Full Text] [Related]
12. Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?
Logez SM; Hutin YJ; Holloway K; Gray R; Hogerzeil HV
J Clin Pharmacol; 2004 Oct; 44(10):1106-13. PubMed ID: 15342611
[TBL] [Abstract][Full Text] [Related]
13. Access to essential medicines for children: the world health organization's global response.
Zucker H; Rägo L
Clin Pharmacol Ther; 2007 Nov; 82(5):503-5. PubMed ID: 17952106
[TBL] [Abstract][Full Text] [Related]
14. Ensuring patient access to essential medicines while minimizing harmful use: a revised World Health Organization tool to improve national drug control policy.
Gilson AM; Maurer MA; Ryan KM; Skemp-Brown M; Husain A; Cleary JF
J Pain Palliat Care Pharmacother; 2011; 25(3):246-51. PubMed ID: 21882978
[TBL] [Abstract][Full Text] [Related]
15. The morally uncomfortable global drug gap.
Cohen-Kohler JC
Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
[TBL] [Abstract][Full Text] [Related]
16. The interpretation of China national essential medicines list 2018.
Zuo W; Mei D; Sun W; Tang X; Niu Z; Gao D; Zhang B
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):191-200. PubMed ID: 31914825
[No Abstract] [Full Text] [Related]
17. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
[TBL] [Abstract][Full Text] [Related]
18. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
19. Benchmarking progress in tackling the challenges of intellectual property, and access to medicines in developing countries.
Musungu SF
Bull World Health Organ; 2006 May; 84(5):366-70. PubMed ID: 16710545
[TBL] [Abstract][Full Text] [Related]
20. Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.
Liu D; Cheng J; Zhang LL; Li YP; Zeng LN; Zhang C; Gui G
J Evid Based Med; 2017 Nov; 10(4):271-280. PubMed ID: 28276634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
